FrancophonIA/ELRC3.0 huggingface dataset:
English: Its structure is derived from the neurotransmitter acetylcholine and acts on nicotinic acetylcholine receptors of the insect nerve synapse.
Maltese: L-istruttura tiegħu hija derivata min-newrotrasmettitur acetylcholine u jaġixxi fuq riċettaturi nikotiniċi ta' acetylcholine fuq is-synapse tan-nerv tal-insett.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Maltese: Informazzjoni dettaljata dwar dan il-prodott mediċinali veterinarju tinsab fuq il-websajt tal-Aġenzija Ewropea dwar il-Mediċini http://www.ema.europa.eu/
English: ROUTE(S) OF ADMINISTRATION Spot-on use
Maltese: MOD(I) TA' AMMINISTRAZZJONI Użu lokalizzat.
English: 4.9 Amounts to be administered and administration route Dosage:
Maltese: 4.9 Ammont li jingħata u l-metodu ta' amministrazzjoni Dożaġġ:
English: For permethrin, the plasma levels remain under the limit of quantification.
Maltese: Għal permethrin, il-livelli tal-plażma jibqgħu taħt il-limitu ta' kwantifikazzjoni.
English: Ticks:
Maltese: Qurdien:
English: Step 4 Use according to 4a or 4b recommendation:
Maltese: Stadju 4 Uża skont ir-rakkomandazzjoni ta' 4a jew 4b:
English: Pyriproxyfen also blocks the development of juvenile stages (larvae and early (pharate) pupae) into adult emergence.
Maltese: Pyriproxyfen jimblokka wkoll l-iżvilupp ta' stadji ġovanili (larvae u papae (farate) bikrija) għall-iżvilupp ta' adulti.
English: Yellow for dogs > 4-10 kg
Maltese: Isfar għal klieb > 4-10 kg
English: Pharmacotherapeutic group: Ectoparasiticides, insecticides and repellents, permethrin combinations.
Maltese: Ektoparasiti, insettiċidi u repellanti, kombinazzjonijiet ta' permethrin Kodiċi ATC veterinarja:
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard boxes of 1, 3, 4, 6, 12, 24 and 48 spot-on applicators
Maltese: TAGĦRIF LI GĦANDU JIDHER FUQ IL-PAKKETT TA' BARRA Kaxxi tal-kartun ta' 1, 3, 4, 6, 12, 24 u 48 applikatur lokalizzat
English: Dinotefuran and permethrin work together, in synergy, for a faster onset of activity in vivo.
Maltese: Dinotefuran u permethrin jaġixxu flimkien f'sinerġija, fejn intwera li dan wassal għal attività aktar mgħaġġla in vivo.
English: Vectra 3D for dogs > 10-25 kg for dogs > 25-40 kg Purple
Maltese: Vectra 3D għal klieb > 10-25 kg għal klieb > 25-40 kg Vjola
English: Dinotefuran has been shown to cross the blood-milk barrier and is excreted in the milk.
Maltese: Dinotefuran intwera li jaqsam il-barriera tad-demm-ħalib u jiġi eliminat fil-ħalib.
English: Dogs over 10 kg and up to 40 kg body weight
Maltese: Klieb aktar minn 10 kg sa 40 kg piż talġisem
English: • In case of accidental spillage onto skin, wash off immediately with soap and water.
Maltese: • F'każ ta' tixrid aċċidentali fuq il-ġilda, aħsel minnufih b'ilma u sapun.
English: Dogs from 1.5 to 4 kg body weight
Maltese: Klieb minn 1.5 sa 4 kg piż tal-ġisem
English: Dogs.
Maltese: DIKJARAZZJONI
English: Studies with each active ingredient (dinotefuran, permethrin or pyriproxyfen) in rats and rabbits have not produced any evidence of toxicity on pregnant or lactating animals.
Maltese: Studji b'kull sustanza attiva (dinotefuran, permethrin jew pyriproxyfen) f'firien u fniek ma pproduċewx evidenza ta' tossiċità fuq annimali tqal jew li jreddgħu..
English: Each spot-on applicator delivers:
Maltese: Kull applikatur lokalizzat jagħti:
English: Teal for dogs > 10-25 kg
Maltese: Blu skur għal klieb > 10-25 kg
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and spot-on applicator after “EXP”.
Maltese: Tużax dan il-prodott mediċinali veterinarju wara d-data ta' skadenza murija fuq il-kartuna u lapplikatur lokalizzat (wara “EXP”).
English: Vectra 3D for dogs > 25-40 kg for dogs > 40 kg
Maltese: Vectra 3D għal klieb > 25-40 kg għal klieb > 40 kg
English: Gastrointestinal (stomach or gut) adverse reactions, such as vomiting or diarrhoea, have also been reported very rarely.
Maltese: Reazzjonijiet gastrointestinali avversi (l-istonku u l-imsaren), bħal remettar jew dijarea, ġew rapportati b'mod rari ħafna.
English: Once bound to these receptors, the agonist action of repeated excitatory impulses kills the insect.
Maltese: Ġaladarba jingħaqad ma' dawn ir-riċettaturi, l-azzjoni agonista ta' impulsi eċitati ripetuti joqtlu lill-insett.
English: This veterinary medicinal product can induce convulsions in cats that could be fatal, due to the unique physiology of this species which is unable to metabolise certain compounds, including permethrin.
Maltese: Dan il-prodott mediċinali veterinarju jista' jinduċi aċċessjonijiet fi qtates li jistgħu jkunu fatali minħabba l-fiżjoloġija unika tal-ispeċi li mhix kapaċi timmetabolizza ċertu komposti, li jinkludu permethrin.
English: Do not use on cats (see ‘Special warnings').
Maltese: Tużax fuq qtates (Ara ‘Prekawzjonijiet speċjali').
English: Dogs over 4 kg and up to 10 kg body weight
Maltese: Klieb akbar minn 4 kg u sa 10 kg piż talġisem
English: Vectra 3D for dogs > 4-10 kg for dogs > 10-25 kg
Maltese: Vectra 3D għal klieb > 4-10 kg għal klieb > 10-25 kg Blu
English: 4.11 Withdrawal period(s)
Maltese: 4.11 Perjod(u/i) ta' tiżmim
English: This veterinary medicine kills and repels ticks (Rhipicephalus sanguineus and Ixodes ricinus ticks are controlled for one month; Dermacentor reticulatus ticks are controlled for up to three weeks).
Maltese: Din il-mediċina veterinarja toqtol u tbiegħed il-qurdien (qurdien ta' Rhipicephalus sanguineus u Ixodes ricinus huma kontrollati għal xahar: qurdien Dermacentor reticulatus huma kkontrollati għal sa tliet ġimgħat).
English: Transient skin redness, itching or other signs of discomfort at the application site have been reported rarely and usually disappear without any treatment and within 24 hours after using the veterinary medicine.
Maltese: Ħmura tal-ġilda temporanja, ħakk jew sinjali oħra ta' skumdità fis-sit t'applikazzjoni ġew rapportati b'mod rari u ġeneralment jisparixxu mingħajr ebda trattament u fi żmien 24 siegħa wara l-użu talmediċina veterinarja.
English: Pale yellow solution.
Maltese: speċjalment tfal.
English: In case of suspicion of dermatitis (itch and skin irritation), seek for veterinary advice.
Maltese: F'każ li d-dermatite hija suspettata (ħakk jew irritazzjoni tal-ġilda) fittex parir mediku.
English: The treatment also provides persistent insecticidal activity for one month against mosquitoes (Aedes aegypti) and stable flies (Stomoxys calcitrans).
Maltese: It-trattament jipprovdi wkoll attività insettiċida persistenti għal xahar wieħed kontra ż-żunżan (Aedes aegypti) u żnażan tal-istalel
English: Red
Maltese: Klieb
English: Spot-on applicator made of a multilayered complex of aluminium and polyethylene (PE) with HDPE, top-sealed with a liner complex (aluminium/polyester/sealable PE layer).
Maltese: In-natura u l-għamla tal-ippakkjar li jmiss mall-prodott L-applikatur lokalizzat hu magħmul minn kumpless ta' diversi saffi ta' aluminju u polyethylene (PE) b'HDPE, bl-għatu ssiġillat b'kumpless inforrat (aluminju/polyester/saff ta' PE).
English: The safety of this veterinary medicine has not been established in dogs younger than 7 weeks or weighing less than 1.5 kg.
Maltese: Is-sigurtà tal-prodott mediċinali veterinarju ma ġietx stabbilita fi klieb li huma iżgħar minn 7 ġimgħat jew li jiżnu inqas minn 1.5 kg.
English: Gastrointestinal signs such as vomiting or diarrhoea have also been reported very rarely.
Maltese: Sinjali gastrointestinali bħal remettar jew dijarea ġew rapportati b'mod rari ħafna.
English: Weight of dog (kg)
Maltese: Piż tal-kelb (kg)
English: Vectra 3D for dogs 1.5-4 kg for dogs > 4-10 kg
Maltese: Vectra 3D għal klieb 1.5-4 kg għal klieb > 4-10 kg Blu skur
English: Fleas:
Maltese: FIS-SUQ
English: Dinotefuran has low affinity to mammalian acetylcholine receptor sites.
Maltese: Dinotefuran għandu affinità baxxa għal siti ta' riċettatur ta' acetylcholine tal-mammiferi.
English: Dogs over 40 kg body weight
Maltese: Klieb aktar minn 40 kg piż tal-ġisem
English: Colour of applicator cap
Maltese: Mhux applikabbli
English: Prevention of flea multiplication for 2 months.
Maltese: Prevenzjoni ta' multiplikazzjoni ta' qurdien għal xahrejn.
English: Transient erythema, pruritus or other signs of discomfort at the application site have been reported rarely and usually disappear spontaneously, within 24 hours following administration of the product.
Maltese: Eritema temporanja, ħakk jew sinjali oħra ta' skumdità fis-sit t'applikazzjoni ġew rapportati b'mod rari u ġeneralment jisparixxu spontanjament, fi żmien 24 siegħa wara l-għoti tal-prodott.
English: INDICATION(S)
Maltese: ATTIV(A/I)
English: Vectra 3D spot-on solution for dogs 1.5-4 kg Vectra 3D spot-on solution for dogs > 4-10 kg Vectra 3D spot-on solution for dogs > 10-25 kg Vectra 3D spot-on solution for dogs > 25-40 kg Vectra 3D spot-on solution for dogs > 40 kg dinotefuran / pyriproxyfen / permethrin
Maltese: Vectra 3D soluzzjoni għal użu lokalizzat għal klieb 1.5-4 kg Vectra 3D soluzzjoni għal użu lokalizzat għal klieb > 4-10 kg Vectra 3D soluzzjoni għal użu lokalizzat għal klieb >10-25 kg Vectra 3D soluzzjoni għal użu lokalizzat għal klieb > 25-40 kg Vectra 3D soluzzjoni għal użu lokalizzat għal klieb > 40 kg
English: (Only one size per box).
Maltese: (Stomoxys calcitrans).
English: Marketing authorisation holder and manufacturer responsible for batch release:
Maltese: Sabiex tevita reazzjonijiet avversi:
English: Step 2: With the other hand, press downwards on the smaller disk until the 2 disks meet evenly.
Maltese: Stadju 2: Bl-id l-oħra, agħfas 'l isfel fuq id-diska iżgħar sakemm iż-żewġ diski jiltaqgħu ma' xulxin Dan itaqqab is-siġill.
English: Ozempic semaglutide
Maltese: Ozempic semaglutid
English: The full EPAR for Ozempic can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The active substance in Ozempic, semaglutide, is a ‘GLP-1 receptor agonist'.
Maltese: Is-sustanza attiva f'Ozempic, is-semaglutid, hija "agonista tar-riċettur GLP-1".
English: Ozempic in these studies compared favourably with other treatments, sitagliptin, exenatide and insulin glargine (which led to reductions of 0.55, 0.92, 0.83 percentage points respectively) and placebo (reductions of up to 0.09 percentage points).
Maltese: F'dawn l-istudji, Ozempic tqabbel b'mod favorevoli ma' kuri oħrajn, sitagliptin, exenatide u insulina glargina (li wasslu għal tnaqqis ta' 0.55, 0.92, 0.83 punt perċentwali rispettivament) u plaċebo (tnaqqis sa 0.09 punti perċentwali).
English: This is a summary of the European public assessment report (EPAR) for Ozempic.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Ozempic.
English: Why is Ozempic approved?
Maltese: Għal xiex ġie approvat Ozempic?
English: Five studies in over 4,000 patients showed that Ozempic lowered levels of HbA1c (a measure of blood glucose) by between 1.2 and 1.8 percentage points over 10 to 13 months.
Maltese: Ħames studji f'aktar minn 4 000 pazjent urew li Ozempic baxxa l-livelli tal-HbA1c (kejl tal-glukożju fiddemm) b'bejn 1.2 u 1.8 punti perċentwali fuq perjodu ta' bejn 10 xhur u 13-il xahar.
English: Ozempic contains the active substance semaglutide.
Maltese: Ozempic fih is-sustanza attiva semaglutid.
English: A further study in over 3,000 diabetes patients at high risk of heart problems showed that overall, heart attack, stroke or death occurred less frequently in patients treated with Ozempic (6.6%) than with placebo (8.9%).
Maltese: Studju ieħor li sar f'aktar minn 3 000 pazjent bid-dijabete b'riskju ogħla ta' problemi tal-qalb wera li, b'mod ġenerali, l-attakki tal-qalb, il-puplesiji jew l-imwiet seħħew b'mod inqas frekwenti f'pazjenti li ġew ikkurati b'Ozempic (6.6 %) milli bil-plaċebo (8.9%).
English: Other information about Ozempic
Maltese: Informazzjoni oħra dwar Ozempic
English: The starting dose of Ozempic is 0.25 mg once a week.
Maltese: Id-doża tal-bidu rakkomandata ta' Ozempic hija ta' 0.25 mg darba f'ġimgħa.
English: After four weeks, this dose should be increased to 0.5 mg.
Maltese: Wara erba' ġimgħat, din id-doża għandha tiżdied għal 0.5 mg.
English: Regarding safety, this was considered in line with that of other medicines of the same class.
Maltese: Fir-rigward tas-sigurtà, din kienet meqjusa li hija fl-istess livell ta' dik ta' mediċini oħrajn tal-istess klassi.
English: Worsening of diabetic retinopathy has also been observed and will be further investigated.
Maltese: Laggravar tar-retinopatija dijabetika ġie osservat ukoll u ser ikompli jiġi investigat.
English: Ozempic can be used on its own in patients who cannot take metformin (another diabetes medicine).
Maltese: Ozempic jista' jintuża waħdu f'pazjenti li ma jistgħux jieħdu l-metformina (mediċina oħra kontra ddijabete).
English: If needed, the dose can be further increased up to a maximum of 1 mg once a week.
Maltese: Jekk ikun meħtieġ, id-doża tista' tkompli tiżdied sa massimu ta' 1 mg darba f'ġimgħa.
English: Serious worsening of diabetic retinopathy (damage to the retina, the light sensitive membrane at the back of the eye) is common (it may affect up to 1 in 10 people).
Maltese: L-aggravar serju ta' retinopatija dijabetika (ħsara fir-retina, il-membrana sensittiva għad-dawl fuq wara tal-għajn) huwa komuni (jista' jaffettwa sa persuna waħda minn kull 10).
English: The most common side effects with Ozempic (which may affect more than 1 in 10 people) include problems with the digestive system, such as diarrhoea, vomiting and nausea (feeling sick).
Maltese: L-effetti sekondarji l-aktar komuni b'Ozempic (li jistgħu jaffettwaw aktar minn persuna waħda minn kull 10) jinkludu problemi bis-sistema diġestiva, bħal dijarea; remettar u nawżja (tħossok imdardar/imdardra).
English: What are the risks associated with Ozempic?
Maltese: X'inhuma r-riskji assoċjati ma' Ozempic?
English: When looking at the three ‘events' separately, fewer patients taking Ozempic had a heart attack or stroke, but rates of death from heart problems were similar in the two groups.
Maltese: Meta wieħed jikkunsidra t-tliet "okkorrenzi" b'mod separat, numru inqas ta' pazjenti li kienu qed jieħdu Ozempic kellhom attakk tal-qalb jew puplesija, iżda r-rati tal-imwiet ikkawżati minn problemi tal-qalb kienu simili fiż-żewġ gruppi.
English: Ozempic is a diabetes medicine used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled.
Maltese: Ozempic huwa mediċina kontra d-dijabete użata flimkien mad-dieta u l-eżerċizzju għall-kura ta' adulti li d-dijabete tat-tip 2 tagħhom ma tkunx ikkontrollata b'mod sodisfaċenti.
English: It can also be used as an ‘add-on' to other diabetes medicines.
Maltese: Jista' jintuża wkoll bħala ‘żieda' ma' mediċini oħrajn kontra d-dijabete.
English: Ozempic is available as a solution for injection in prefilled pens and can only be obtained with a prescription.
Maltese: Barra minn hekk, ir-riżultati indikaw li l-kura b'Ozempic kienet assoċjata ma' tnaqqis ta' benefiċċju fil-piż tal-ġisem.
English: For the full list of all side effects and restrictions with Ozempic, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji u r-restrizzjonijiet kollha b'Ozempic, ara l-fuljett ta' tagħrif.
English: It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food.
Maltese: Din taġixxi bl-istess mod bħall-GLP-1 (ormon li tipproduċi l-musrana) billi żżid l-ammont ta' insulina rilaxxat mill-frixa bħala rispons għall-ikel.
English: Ozempic was also shown to be effective at reducing the occurrence of serious health complications associated with diabetes such as heart attack and stroke.
Maltese: Ozempic wera li huwa effettiv ukoll fit-tnaqqis tal-okkorrenza ta' kumplikazzjonijiet serji tas-saħħa assoċjati maddijabete bħall-attakki tal-qalb u l-puplesiji.
English: Ozempic was shown to be effective at controlling blood glucose levels.
Maltese: L-effetti sekondarji li jaffettwaw is-sistema diġestiva huma meqjusin li huma kontrollabbli.
English: These are mild or moderate in severity and of short duration.
Maltese: Dawn l-effetti normalment ikunu ħfief jew moderati fis-severità tagħhom u ma jippersistux fit-tul.
English: 720 ELISA Units
Maltese: Unità ELISA
English: 1 dose (1 ml) contains: Hepatitis A virus (inactivated)1,2
Maltese: 1 doża (1 ml) fiha: Virus tal-Epatite A (mhux attivat)1,2
English: 1Produced on human diploid (MRC-5) cells 2Adsorbed on aluminium hydroxide, hydrated
Maltese: 1Prodott fuq ċelloli tad-diplojde umani (MRC-5) 2Adsorbit fuq aluminium hydroxide, idratat
English: 3Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 4Adsorbed on aluminium phosphate
Maltese: 3Prodott f'ċelloli tal-ħmira (Saccharomyces cerevisiae) b'teknoloġija rikombinanti tad-DNA 4Adsorbit fuq aluminium phosphate
English: Hepatitis B surface antigen3,4
Maltese: Antiġen tal-wiċċ tal-Epatite B3,4
English: 1 needle
Maltese: Isem (ivvintat)
English: 1 pre-filled syringe +
Maltese: 10 siringi mimlijin għal-lest + 10 labriet
English: Glustin pioglitazone
Maltese: Glustin pijoglitażonu
English: It is available as tablets (15, 30 and 45 mg).
Maltese: Jiġi bħala pilloli (15, 30 u 45 mg).
English: Other information about Glustin:
Maltese: Informazzjoni oħra dwar Glustin:
English: The full EPAR for Glustin can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Maltese: L-EPAR sħiħ għal Glustin jinsab fis-sit elettroniku tal-Aġenzija ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Glustin is a medicine that contains the active substance pioglitazone.
Maltese: Glustin huwa mediċina li fiha s-sustanza attiva pijoglitażonu.
English: This is a summary of the European public assessment report (EPAR) for Glustin.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Glustin.
English: Glustin has been compared with placebo (a dummy treatment), metformin and gliclazide (a sulphonylurea) in a number of studies.
Maltese: Glustin tqabbel ma' plaċebo (kura finta), mal-metformina u mal-gliċlażide (tip ta' sulfonilurea) f'diversi studji.
English: Why has Glustin been approved?
Maltese: Għaliex ġie approvat Glustin?
English: The doses of Glustin may need to be adjusted when given with some other medicines such as gemfibrozil (used to lower cholesterol) or rifampicin (an antibiotic used to treat tuberculosis).
Maltese: Jista' jkun hemm bżonn li d-dożi ta' Glustin jiġu aġġustati meta jingħataw ma' xi mediċini oħrajn bħallgemfibrożil (użata biex tbaxxi l-kolesterol) jew ir-rifampiċina (antibijotiku użat fil-kura tat-tuberkulożi).
English: The most common side effects with Glustin (seen in between 1 and 10 patients in 100) are upper respiratory tract infection (colds), hypoaesthesia (reduced sense of touch), visual disturbance, bone fractures and increased weight.
Maltese: L-effetti sekondarji l-aktar komuni bi Glustin (li dehru f'bejn pazjent 1 u 10 minn 100) huma infezzjonijiet tan-nifs tan-naħa ta' fuq (irjiħat), ipostesija (tnaqqis fis-sensittività tal-mess), disturbi viżivi, ksur fl-għadam u żieda fil-piż.
English: What is Glustin?
Maltese: X'inhu Glustin?
English: The recommended starting dose of Glustin is 15 or 30 mg once a day.
Maltese: Id-doża tal-bidu rakkomandata ta' Glustin hija 15 jew 30 mg darba kuljum.
English: Glustin led to a decrease in the level of HbA1c, indicating that blood glucose levels had been reduced at doses of 15, 30 and 45 mg. Glustin on its own was shown to be as effective as metformin and gliclazide.
Maltese: Glustin wassal għal tnaqqis fil-livell tal-HbA1c, li jindika li l-livelli tal-glukożju fid-demm ikunu tnaqqsu f'dożi ta' 15, 30 u 45 mg.
English: What is the risk associated with Glustin?
Maltese: X'inhu r-riskju assoċjat ma' Glustin?
English: The company that markets Glustin will produce educational material for doctors prescribing the medicine, which will cover the possible risk of heart failure and bladder cancer with treatments that contain pioglitazone, the criteria for selecting patients and the need to review treatment regularly and stop treatment if patients are no longer benefiting.
Maltese: Il-kumpanija li tqiegħed Glustin fis-suq se tipproduċi materjal edukattiv għat-tobba li jippreskrivu lmediċina, li se jkopri r-riskju possibbli ta' insuffiċjenza tal-qalb u kanċer fil-bużżieqa tal-urina bil-kuri li fihom il-pijoglitażonu, il-kriterji għall-għażla tal-pazjenti u l-ħtieġa ta' rieżami regolari tal-kura u li lkura titwaqqaf jekk il-pazjenti ma jibqgħux jibbenefikaw minnha.
English: Some studies also looked at combining Glustin with a sulphonylurea, insulin or metformin, or with the combination of metformin and a sulphonylurea.
Maltese: Xi studji stħarrġu wkoll il-kombinazzjoni ta' Glustin mas-sulfonilurea, mal-insulina jew malmetformina, jew mal-kombinazzjoni tal-metformina u s-sulfonilurea.
English: Glustin also improved the glucose control obtained in type 2 diabetes when it was added to existing treatment with a sulphonylurea, insulin or metformin, or the combination of metformin and a sulphonylurea.
Maltese: Glustin tejjeb ukoll il-kontroll tal-glukożju miksub fid-dijabete tat-tip 2 meta żdied mal-kura eżistenti bis-sulfonilurea, l-insulina jew l-metformina, jew mal-kombinazzjoni tal-meformina u s-sulfonilurea.
English: • on its own in patients for whom metformin (another diabetes medicine) is not suitable;
Maltese: • waħdu f'pazjenti li ma jistgħux jieħdu l-metformina (mediċina oħra kontra d-dijabete);
English: • together with both metformin and a sulphonylurea in patients who are not satisfactorily controlled despite treatment with two medicines by mouth;
Maltese: • f'kombinazzjoni kemm mal-metformina kif ukoll mas-sulfonilurea fil-pazjenti li mhumiex ikkontrollati b'mod sodisfaċenti minkejja kura b'żewġ mediċini mill-ħalq;
English: If Glustin is used in combination with other diabetes medicines, other side effects may occur.
Maltese: Jekk Glustin jintuża f'kombinazzjoni ma' mediċini oħra kontra ddijabete, jistgħu jiżviluppaw effetti sekondarji oħrajn.
English: The active substance in Glustin, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Maltese: Is-sustanza attiva fi Glustin, il-pijoglitażonu, tagħmel iċ-ċelloli (tax-xaħam, tal-muskoli u tal-fwied) aktar sensittivi għall-insulina, li jfisser li l-ġisem jibda jagħmel użu aħjar mill-insulina li jipproduċi.
English: How has Glustin been studied?
Maltese: Kif ġie studjat Glustin?
English: For the full list of all side effects reported with Glustin, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji kollha rrapportati bi Glustin, ara l-fuljett ta' tagħrif.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Glustin on 11 October 2000.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Glustin fil-11 ta' Ottubru 2000.
English: Almost 7,000 patients received Glustin in all of the studies combined.
Maltese: Kważi 7,000 pazjent irċevew Glustin fl-istudji kollha f'daqqa.
English: The CHMP decided that Glustin's benefits are greater than its risks and recommended that it be given marketing authorisation.
Maltese: Is-CHMP iddeċieda li l-benefiċċji ta' Glustin huma akbar mir-riskji tiegħu u rrakkomanda li jingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: • in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea (another type of diabetes medicine) when metformin is not suitable in patients who are not satisfactorily controlled on a sulphonylurea alone;
Maltese: • f'kombinazzjoni mal-metformina f'pazjenti li ma jkunux ikkontrollati b'mod sodisfaċenti bilmetformina weħidha, jew bis-sulfonilurea (tip ieħor ta' mediċina kontra d-dijabete) meta lmetformina ma tkunx adatta f'pazjenti li ma jkunux ikkontrollati b'mod sodisfaċenti bis-sulfonilurea weħidha;